CIRCULATING PROSTACYCLIN MAY BE REDUCED IN DIABETES
暂无分享,去创建一个
C. Dollery | E. Kohner | M. Porta | J. Webster | P. Lewis | C. Hensby | L. Friedman
[1] C. Dollery,et al. The quantitative analysis of 6-keto PGF1 alpha in biological fluids by stable isotope dilution utilizing gas chromatography-mass spectrometry (GC-MS) [proceedings]. , 1980, British journal of pharmacology.
[2] M. Mitchell,et al. PROSTACYCLIN AND THROMBOXANE METABOLITES IN DIABETES , 1979, The Lancet.
[3] H. Sinzinger,et al. PROSTACYCLIN GENERATION IN ATHEROSCLEROTIC ARTERIES , 1979, The Lancet.
[4] M. Schydlower,et al. Coexistence of deficiency in alpha1 antitrypsin and in growth hormone. , 1979, The New England journal of medicine.
[5] H. Sinzinger,et al. Coexistence of deficiency in alpha1 antitrypsin and in growth hormone. , 1979 .
[6] J. Elder,et al. VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MAN , 1979, The Lancet.
[7] D. Weatherall,et al. Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias. , 1978, Clinical science and molecular medicine.
[8] A. Dembińska-kieć,et al. The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits. , 1977, Prostaglandins.